Differential B-lymphocyte regulation by CD40 and its viral mimic, latent membrane protein 1.
about
Epstein-Barr virus immortalization of human B-cells leads to stabilization of hypoxia-induced factor 1 alpha, congruent with the Warburg effectBCR-signalling synergizes with TLR-signalling for induction of AID and immunoglobulin class-switching through the non-canonical NF-κB pathwayA lymphomagenic role for HIV beyond immune suppression?Epstein-Barr virus in systemic lupus erythematosus, rheumatoid arthritis and multiple sclerosis—association and causationRoles of tumor necrosis factor receptor associated factor 3 (TRAF3) and TRAF5 in immune cell functionsRegulation of Aicda expression and AID activityEpstein - Barr virus transforming protein LMP-1 alters B cells gene expression by promoting accumulation of the oncoprotein ΔNp73αPathogenetic importance and therapeutic implications of NF-κB in lymphoid malignancies.Interactions between glucocorticoid treatment and cis-regulatory polymorphisms contribute to cellular response phenotypes.The latent membrane protein 1 (LMP1) oncogene of Epstein-Barr virus can simultaneously induce and inhibit apoptosis in B cells.Roles of the kinase TAK1 in TRAF6-dependent signaling by CD40 and its oncogenic viral mimic, LMP1The germinal center kinase TNIK is required for canonical NF-κB and JNK signaling in B-cells by the EBV oncoprotein LMP1 and the CD40 receptor.A new model of LMP1-MYC interaction in B cell lymphoma.Phospho-specific flow cytometry identifies aberrant signaling in indolent B-cell lymphomaT cell-B cell thymic cross-talk: maintenance and function of thymic B cells requires cognate CD40-CD40 ligand interaction.Molecular mechanisms of TNFR-associated factor 6 (TRAF6) utilization by the oncogenic viral mimic of CD40, latent membrane protein 1 (LMP1).EBV LMP1, a viral mimic of CD40, activates dendritic cells and functions as a molecular adjuvant when incorporated into an HIV vaccine.Scaffold protein JLP is critical for CD40 signaling in B lymphocytes.LMP1-deficient Epstein-Barr virus mutant requires T cells for lymphomagenesis.TRAF1 Coordinates Polyubiquitin Signaling to Enhance Epstein-Barr Virus LMP1-Mediated Growth and Survival Pathway ActivationThe MS Risk Allele of CD40 Is Associated with Reduced Cell-Membrane Bound Expression in Antigen Presenting Cells: Implications for Gene FunctionGenome-wide siRNA screen for mediators of NF-κB activationEpstein-Barr virus IL-10 engages IL-10R1 by a two-step mechanism leading to altered signaling propertiesEpstein-Barr virus Latent Membrane Protein 2A (LMP2A)-mediated changes in Fas expression and Fas-dependent apoptosis: Role of Lyn/Syk activation.Up-regulation and pre-activation of TRAF3 and TRAF5 in inflammatory bowel disease.Epstein-Barr virus in oral shedding of children with multiple sclerosis.Epstein-Barr Virus Oncoprotein LMP1 Mediates Epigenetic Changes in Host Gene Expression through PARP1.Prognostic significance of signal transducer and activator of transcription 5 and 5b expression in Epstein-Barr virus-positive patients with chronic lymphocytic leukemiaHow human tumor viruses make use of autophagy.TRAF6 is a critical regulator of LMP1 functions in vivo.Epstein-Barr virus-associated B-cell lymphomas: pathogenesis and clinical outcomes.The role of CD40/CD40L and interferon regulatory factor 4 in Hodgkin lymphoma microenvironment.The evidence for a role of B cells in multiple sclerosis.Impact of EBV essential nuclear protein EBNA-3C on B-cell proliferation and apoptosis.Regulation of PI-3-Kinase and Akt Signaling in T Lymphocytes and Other Cells by TNFR Family MoleculesRoles for TNF-receptor associated factor 3 (TRAF3) in lymphocyte functions.Mechanisms and consequences of constitutive NF-κB activation in B-cell lymphoid malignancies.Signaling mechanisms regulating B-lymphocyte activation and tolerance.An EBV recombinant deleted for residues 130-159 in EBNA3C can deregulate p53/Mdm2 and Cyclin D1/CDK6 which results in apoptosis and reduced cell proliferation.Induction of an altered CD40 signaling complex by an antagonistic human monoclonal antibody to CD40.
P2860
Q24294513-4F591D42-0986-410E-8449-4C402DC43740Q24632504-B72EB37F-2A43-4655-B256-F423CC986592Q26771672-80440FB7-69A6-487D-ABD6-BABBC3870879Q26830464-D8267DD1-2D5E-41AD-BF6A-C3FE73161FF7Q26853280-44DA4413-3DF2-4F81-B83A-09B8F6A73B2EQ26853622-D095D574-FD2C-400D-A9EB-9673290A5943Q28487983-4F84303A-0B17-465E-AA87-411B96EF1E4EQ33889168-E33E071F-81C7-4040-9020-49F50A1B5B8BQ33959230-3AB4C5E0-B929-4881-8D7F-1967DA404FD1Q34253049-CC49689E-1D53-4C77-B482-FD6CD6AA3229Q34364910-8523385F-28CB-472F-B86F-AA32E9BBE65DQ34384112-47599842-0F20-4328-BD9B-89470A6F39EFQ34395376-AEAAA6AB-C211-4910-9FB0-E4AFED83BFC7Q34448586-401ADDC4-0F51-4471-8083-52DF45A85562Q34551079-462577A1-1D52-48F6-94A1-4721B9293BBDQ34696221-E6C76E50-F6F2-40C7-B8B0-F20C3CAA851DQ35096745-86D77044-B4E7-4F74-9DE6-B3CA62A12551Q35126555-3B49905E-33FB-49F2-82F3-B3B4928A5112Q35242466-F4CED41E-BC88-4306-B6A9-6E2C3B393102Q35634395-785503F5-6494-463A-A944-9C36B4F5FC29Q35661793-A3D58F4F-050D-4143-AB30-A03CEC621AECQ35787254-52385C18-137D-49DE-952D-8F6C8372B56DQ36137341-30B3145C-EBDA-4FBC-A4F5-D73AFE192B68Q36199894-70837D1E-1622-45E3-AE41-D38AFBD920A2Q36540116-94C61491-0D20-4D6E-9F62-AA721E95C1C0Q37251625-2BCEC4A6-8F5A-4B49-872D-1432F62C9570Q37253033-C3292957-574B-4910-9DAE-04F5910A695BQ37321119-59D64C36-D8C4-453F-BDA5-9932C119D83EQ37512260-ACA8AE45-EE09-496D-80A2-5EC0B872DB9FQ37610522-90D451CB-0FD6-41A9-AC2A-6D12896226E8Q37849461-CC15DA94-8F9E-4856-A91F-FDA29FCEB5A4Q37901020-760D2127-8300-4517-8DD6-113146AC7704Q37993033-F83A2DD8-6278-41D8-A7AE-F8EA3BF6470DQ38086861-E3E7AFD2-2965-4777-97B5-73531E3ABC6CQ38113962-832F01C7-8EBA-4744-883E-65BE639B1232Q38179139-C883E9E4-88DA-432D-9F7C-DF77AAA13CA3Q38182355-02CB70BE-1446-4035-8D81-519C23EF9395Q38334794-81113E28-368D-4E28-B02D-CE718CBB0B93Q38791533-4A284573-BF04-47CE-85FA-51BA0A3A837CQ38896847-0A7DF289-B79B-4230-AAF6-08F5698CC49F
P2860
Differential B-lymphocyte regulation by CD40 and its viral mimic, latent membrane protein 1.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Differential B-lymphocyte regu ...... ic, latent membrane protein 1.
@en
Differential B-lymphocyte regu ...... ic, latent membrane protein 1.
@nl
type
label
Differential B-lymphocyte regu ...... ic, latent membrane protein 1.
@en
Differential B-lymphocyte regu ...... ic, latent membrane protein 1.
@nl
prefLabel
Differential B-lymphocyte regu ...... ic, latent membrane protein 1.
@en
Differential B-lymphocyte regu ...... ic, latent membrane protein 1.
@nl
P2093
P2860
P1476
Differential B-lymphocyte regu ...... ic, latent membrane protein 1.
@en
P2093
Gail A Bishop
John P Graham
Kelly M Arcipowski
P2860
P304
P356
10.1111/J.1600-065X.2010.00932.X
P577
2010-09-01T00:00:00Z